Article info

Original research
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies

Authors

  1. Correspondence to Dr Amy A Lo; lo.amy{at}gene.com; Dr Oliver A Zill; oliver{at}init.bio
View Full Text

Citation

Lo AA, Wallace A, Oreper D, et al
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies

Publication history

  • Accepted August 15, 2021
  • First published October 1, 2021.
Online issue publication 
October 01, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.